<DOC>
	<DOCNO>NCT01258192</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety neoadjuvant chemotherapy nab-paclitaxel plus cisplatin stage Ⅱ-Ⅲ esophageal squamous cell carcinoma patient .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin Stage Ⅱ-Ⅲ Esophageal Cancer Patients</brief_title>
	<detailed_description>A surgical resection currently prefer treatment esophageal cancer tumor consider resectable without evidence distant metastases.A high percentage radical resection report study use neoadjuvant chemotherapy follow surgery versus surgery alone.The neoadjuvant chemotherapy may improve overall survival . Neoadjuvant chemotherapy administration paclitaxel combine cisplatin carboplatin show effectively.Nanoparticle albumin-bound ( nab ) -paclitaxel good efficacy practically eliminate risk hypersensitivity reaction associate solvent-based paclitaxel.We try evaluate efficacy safety neoadjuvant chemotherapy nab-paclitaxel plus cisplatin stage Ⅱ-Ⅲ esophageal squamous cell carcinoma patient .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologic diagnosis squamous cell carcinoma esophagus . Preoperative stage ⅡⅢ endoscopic ultrasound , CT chest abdomen , esophagogram . Age range 18 70 year . Patients must receive prior anticancer therapy . Performance status 0 1 Estimated life expectancy least 6 month . Tumor measure accord RECIST criterion Signed informed consent document file . Females childbearing potential must negative serum pregnancy Adequate organ function include follow : Bone marrow : Absolute neutrophil count ( ANC ) great equal 1.5×109/L Platelets great equal 80×109/L Haemoglobin great equal 80g/L Hepatic : total bilirubin less equal 1.5 time upper limit normal ( ULN ) , Alanine transaminase ( ALT ) aspartate transaminase ( AST ) less equal 2.5 time ULN Renal : calculated creatinine clearance rate≥60ml/min . test within 7 day prior study enrollment . Carcinoma upper part esophagus Histologic diagnosis adenocarcinoma esophagus . Prior treatment esophageal cancer . Active infection . Pregnant breast feeding . History significant neurological mental disorder , include seizure dementia . Prior invasive malignancy 5 year ( except carcinoma situ ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>esophageal squamous cell carcinoma</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>albumin-bound paclitaxel</keyword>
	<keyword>cisplatin</keyword>
</DOC>